Novo Nordisk A/S to Expand Beijing R&D Center for $100 Million

BEIJING, Nov 12, 2010 (SinoCast Daily Business Beat via COMTEX) -- Novo Nordisk A/S (NYSE: NVO | PowerRating), one of the pioneers in the global health care market, announced today that it would inject as much as USD 100 million to expand its R&D center in Beijing for a business expansion in the world's most populous market.

Back to news